PyInvesting

Market research

ORTINLABSS.NSE Ortin Laboratories Limited

NSE INR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
132M
P/E ratio
11.39
Analyst target
Not available
Dividend yield
0.0%
Beta
1.43

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Ortin Laboratories Limited is currently in a long term downtrend where the price is trading 3.7% below its 200 day moving average.

From a valuation standpoint, the stock is 97.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.

Ortin Laboratories Limited's total revenue sank by 4.4% to $518M since the same quarter in the previous year.

Its net income has increased by 134.6% to $6M since the same quarter in the previous year.

Finally, its free cash flow fell by 15.0% to $19M since the same quarter in the previous year.

Based on the above factors, Ortin Laboratories Limited gets an overall score of 2/5.